Predictive model of nocturnal hypoglycemia based on the data from mobile application for glucose monitoring
Heading: Endocrinology Article type: Original article
Authors: Rusanov A.N., Rodionova T.I.
Organization: Saratov State Medical University
Objective: to develop a prognostic algorithm of nocturnal hypoglycemia (NH) based on the glucose monitoring mobile application data. Material and methods. The retrospective analysis of 524 continuous glucose monitoring (CGM) profiles of patients with type 1 diabetes mellitus was performed. CGM was performed using the Medtronic iPro2 system for 6-7 days, overnight periods of CGM were analyzed to identify systematic NH. There were 239 patients included in the study, among them 65 (27.1%) were identified as having systematic NH. Models of 7-point glycemic profiles were built and their data were uploaded to the DiaLog GM mobile application to calculate standardized glucose monitoring parameters. The prognostic model of NH was developed based on the logistic regression method. Results. According to the results of regression analysis the most significant predictors of NH included in the prognostic model were: glycated hemoglobin (p=0.001), using of insulin pump therapy (p=0.001), time below target range level 1 (p<0.001), coefficient of variation for glucose (p=0.02). The area under the ROC curve for the prediction model was 0.917; the optimal cut-off point for the predicted probability of NH was 0.317, with model sensitivity of 85% and specificity of 90%. Conclusions. The developed prediction model based on data from a specialized mobile application allows to improve the existing approaches to NH risk assessment due to higher predictive ability.
Bibliography:
1. Yeh JS, Sung SH, Huang HM, et al. Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis. Acta Diabetol. 2016; 53 (3): 377-92. DOI: 10.1007/S00592-015-0803-3
2. Klimontov VV. Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches. Diabetes Mellitus. 2018; 21 (6): 513-23. DOI: 10.14341/DM9597
3. Olafsdottir AF, Polonsky W, Bolinder J, et al. A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technol Ther. 2018; 20 (4): 274-84. DOI: 10.1089/dia. 2017.0363
4. Divan V, Greenfield M, Morley CP, Weinstock RS. Perceived burdens and benefits associated with continuous glucose monitor use in type 1 diabetes across the lifespan. J Diabetes Sci Technol. 2022; 16 (1): 88-96. DOI: 10.1177/1932296820978769
5. Kompala T, Wong J, Neinstein A. Diabetes specialists value continuous glucose monitoring despite challenges in prescribing and data review process. J Diabetes Sci Technol. 2023; 17 (5): 1265-73. DOI: 10.1177/19322968221088267
6. Schrangl P, Reiterer F, Heinemann L, et al. Limits to the evaluation of the accuracy of continuous glucose monitoring systems by clinical trials. Biosensors (Basel). 2018; 8 (2): 50. DOI: 10.3390/bios8020050
7. Klimontov VV, Myakina NE. Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin. Diabetes Metab Syndr. 2017; 11 (2): 119-24. DOI: 10.1016/j.dsx.2016.08.023
8. Sakurai K, Kawai Y, Yamazaki M, Komatsu M. Prediction of lowest nocturnal blood glucose level based on self-monitoring of blood glucose in Japanese patients with type 2 diabetes. J Diabetes Complications. 2018; 32 (12): 1118-23. DOI: 10.1016/j.jdiacomp.2018.09.007
9. Wang S, Tan Z, Wu T, et al. Largest amplitude of glycemic excursion calculating from self-monitoring blood glucose predicted the episodes of nocturnal asymptomatic hypoglycemia detecting by continuous glucose monitoring in outpatients with type 2 diabetes. Front Endocrinol (Lausanne). 2022; 13: 858912. DOI: 10.3389/fendo.2022.858912
10. Fleming GA, Petrie JR, Bergenstal RM, et al. Diabetes digital app technology: Benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia. 2020; 63 (2): 229-41. DOI: 10.1007/s00125-019-05034-1
11. Doupis J, Festas G, Tsilivigos C, et al. Smartphone-based technology in diabetes management. Diabetes Ther. 2020; 11 (3): 607-19. DOI: 10.1007/s13300-020-00768-3
12. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of Specialized Diabetes Care. Ed. by I.I. Dedov, Shestakova M.V., Mayorov A.Yu. 11
Edition. Diabetes mellitus. 2023; 26 (2S): 1-157.
13. American Diabetes Association Professional Practice Committee. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024. Diabetes Care. 2024; 47 (Suppl. 1): 111-25. DOI: 10.2337/dc24-S006
14. Rusanov AN, Rodionova Tl. A new computer algorithm for calculating the mean amplitude of glycemic excursions using self-monitoring blood glucose data. Modern Problems of Science and Education. 2020; (3): 132. DOI: 10.17513/spno.29909
15. Vu L, Kefayati S, Ide T, et al. Predicting nocturnal hypoglycemia from continuous glucose monitoring data with extended prediction horizon. AMIAAnnu Symp Proc. 2020; (2019): 874-82. PMID: 32308884
16. Mosquera-Lopez C, Dodier R, Tyler NS, et al. Predicting and preventing nocturnal hypoglycemia in type 1 diabetes using big data analytics and decision theoretic analysis. Diabetes Technol Ther. 2020; 22 (11): 801-11. DOI: 10.1089/dia.2019.0458
17. Zhang L, Yang L, Zhou Z. Data-based modeling for hypoglycemia prediction: Importance, trends, and implications for clinical practice. Front Public Health. 2023; (11): 1044059. DOI: 10.3389/fpubh.2023.1044059
18. Rodbard D. Glucose variability: A review of clinical applications and research developments. Diabetes Technol Ther. 2018; 20 (S2): S25-215. DOI:10.1089/dia.2018.0092
| Attachment | Size |
|---|---|
| 2024_02_171-176.pdf | 735.96 KB |




